Numinus Wellness Inc. will host the clinics for the extension of the MAPS study.
The Calgary-based life sciences company hopes to develop treatments for mental health conditions.
Sublingual or the administration of medicines under the tongue allows for quick absorption.
The Toronto company is developing a psychedelic drug for anxiety disorders.
Australian researcher cites need to explore ethical issues regarding the use of psychedelics as medicine.
People with obesity and diabetes may have an alternative way to get better with the psychedelic substance psilocybin.